Patient Blood Management Market (2026 - 2035)

ID: MRFR/HC/7326-HCR 112 Pages Vikita Thakur Last Updated: October 14, 2026
Patient Blood Management Market Research Report Information By Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole Blood, Plasma), By End-User (Blood Banks, Hospitals, Diagnostic Clinics, Pathology Labs), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035
Patient Blood Management Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)6.38%
2025 Market SizeUSD 15.42 Billion
2035 Market SizeUSD 28.76 Billion
Key Players
Haemonetics Corporation
Terumo Corporation
Fresenius Kabi
Grifols
Werfen
F. Hoffmann-La Roche
Opportunities
  • Program Rollouts in Emerging Health Systems
  • Data Analytics and Outcome-Based Service Models
  • Outpatient Anemia Clinics and Surgical Prehabilitation
  1. 1 Market Summary | |
  2. 2 Key Report Takeaways | |
    1. 2.1 By End-user | |
    2. 2.2 By Region | |
  3. 3 Market Size and Forecast (2021–2035) | |
  4. 4 Driver Impact Analysis | |
    1. 4.1 Rising Volume of Complex Surgeries | |
    2. 4.2 Value-Based Reimbursement Models | |
    3. 4.3 Accreditation and Stewardship Programs | |
    4. 4.4 High Prevalence of Preoperative Anemia | |
    5. 4.5 Constrained Blood Supply and Donor Shortages | |
    6. 4.6 Automation of Blood Center Workflows | |
  5. 5 Restraints Impact Analysis | |
    1. 5.1 High Capital Cost of Instruments | |
    2. 5.2 Uneven Program Adoption and Clinician Inertia | |
    3. 5.3 Shortage of Trained Transfusion Staff | |
    4. 5.4 Limited Reimbursement for PBM Services | |
    5. 5.5 Software Interoperability Barriers | |
  6. 6 Opportunities | |
    1. 6.1 Program Rollouts in Emerging Health Systems | |
    2. 6.2 Data Analytics and Outcome-Based Service Models | |
    3. 6.3 Outpatient Anemia Clinics and Surgical Prehabilitation | |
    4. 6.4 AI-Driven Transfusion Decision Support | |
    5. 6.5 Bloodless Medicine and Specialized Care Pathways | |
  7. 7 Regional Market Share and Country-Level Analysis | |
    1. 7.1 North America | | |
      1. 7.1.1 US | | |
      2. 7.1.2 Canada | | |
      3. 7.1.3 Mexico | |
    2. 7.2 Europe | | |
      1. 7.2.1 Germany | | |
      2. 7.2.2 UK | | |
      3. 7.2.3 France | | |
      4. 7.2.4 Italy | | |
      5. 7.2.5 Spain | | |
      6. 7.2.6 Nordic Countries | | |
      7. 7.2.7 Russia | | |
      8. 7.2.8 Rest of Europe | |
    3. 7.3 Asia-Pacific | | |
      1. 7.3.1 China | | |
      2. 7.3.2 India | | |
      3. 7.3.3 Japan | | |
      4. 7.3.4 South Korea | | |
      5. 7.3.5 ASEAN | | |
      6. 7.3.6 Rest of Asia-Pacific | |
    4. 7.4 South America | | |
      1. 7.4.1 Brazil | | |
      2. 7.4.2 Argentina | | |
      3. 7.4.3 Rest of South America | |
    5. 7.5 Middle East & Africa | | |
      1. 7.5.1 Saudi Arabia | | |
      2. 7.5.2 UAE | | |
      3. 7.5.3 South Africa | | |
      4. 7.5.4 Egypt | | |
      5. 7.5.5 Rest of MEA | |
  8. 8 Future Outlook (2026–2035) | |
    1. 8.1 AI and Predictive Transfusion Management | |
    2. 8.2 Value-Based Contracting and Platform Economics | |
    3. 8.3 Demographics and Blood Supply Resilience | |
    4. 8.4 Sustainability and Waste Reduction | |
  9. 9 Segmentation Analysis | |
    1. 9.1 By End-user | | |
      1. 9.1.1 Hospitals & Clinics | | |
      2. 9.1.2 Blood Banks | | |
      3. 9.1.3 Diagnostic Centers & Laboratories | | |
      4. 9.1.4 Others | |
  10. 10 Competitive Landscape | |
    1. 10.1 Market Concentration Analysis | |
    2. 10.2 Competitive Benchmarking Matrix | |
    3. 10.3 Company Profiles | | |
      1. 10.3.1 Haemonetics Corporation | | |
      2. 10.3.2 Terumo Corporation | | |
      3. 10.3.3 Fresenius Kabi | | |
      4. 10.3.4 Grifols | | |
      5. 10.3.5 Werfen | | |
      6. 10.3.6 F. Hoffmann-La Roche | | |
      7. 10.3.7 Abbott Laboratories | | |
      8. 10.3.8 Siemens Healthineers | | |
      9. 10.3.9 Bio-Rad Laboratories | | |
      10. 10.3.10 LivaNova | |
  11. 11 Recent News & Developments | |
  12. 12 Report Scope and Methodology | |
  13. 13 Detailed Sources and Citations | |
  14. 14 Frequently Asked Questions (FAQs) | | LIST OF TABLES | |
  15. TABLE 1 Global Market Size & Forecast, by Revenue (USD Billion), 2021–2035 | |
  16. TABLE 2 Global Market – Year-over-Year Growth Analysis, 2021–2035 | |
  17. TABLE 3 Driver Impact Analysis | |
  18. TABLE 4 Restraints Impact Analysis | |
  19. TABLE 5 Global Market Size, by Region, 2021–2035 (USD Billion) | |
  20. TABLE 6 North America Market Size, by Country, 2021–2035 (USD Billion) | |
  21. TABLE 7 Europe Market Size, by Country, 2021–2035 (USD Billion) | |
  22. TABLE 8 Asia-Pacific Market Size, by Country, 2021–2035 (USD Billion) | |
  23. TABLE 9 South America Market Size, by Country, 2021–2035 (USD Billion) | |
  24. TABLE 10 Middle East & Africa Market Size, by Country, 2021–2035 (USD Billion) | |
  25. TABLE 11 Global Market Size, by End-user, 2021–2035 (USD Billion) | |
  26. TABLE 12 North America Market Size, by End-user, 2021–2035 (USD Billion) | |
  27. TABLE 13 Europe Market Size, by End-user, 2021–2035 (USD Billion) | |
  28. TABLE 14 Asia-Pacific Market Size, by End-user, 2021–2035 (USD Billion) | |
  29. TABLE 15 South America Market Size, by End-user, 2021–2035 (USD Billion) | |
  30. TABLE 16 Middle East & Africa Market Size, by End-user, 2021–2035 (USD Billion) | |
  31. TABLE 17 Competitive Benchmarking Matrix, 2025 | |
  32. TABLE 18 Recent Developments & Strategic Announcements, 2023–2025 | |
  33. TABLE 19 Report Scope and Methodology | |
  34. TABLE 20 Detailed Sources and Citations | | LIST OF FIGURES | |
  35. FIGURE 1 Market Dynamics Overview – Drivers, Restraints, Opportunities | |
  36. FIGURE 2 Industry Value Chain Analysis | |
  37. FIGURE 3 Porter's Five Forces Analysis | |
  38. FIGURE 4 Global Market Size Trend, 2021–2035 (USD Billion) | |
  39. FIGURE 5 Global Market Share, by End-user, 2025 (%) | |
  40. FIGURE 6 Global Market Share, by Region, 2025 (%) | |
  41. FIGURE 7 North America Market Share, by Country, 2025 (%) | |
  42. FIGURE 8 Europe Market Share, by Country, 2025 (%) | |
  43. FIGURE 9 Asia-Pacific Market Share, by Country, 2025 (%) | |
  44. FIGURE 10 South America Market Share, by Country, 2025 (%) | |
  45. FIGURE 11 Middle East & Africa Market Share, by Country, 2025 (%) | |
  46. FIGURE 12 Competitive Landscape – Estimated Revenue Share of Key Players, 2025

Segmentation Quick Reference

DimensionSub-SegmentsDominant SegmentFastest Growing Segment
By End-userHospitals & Clinics; Blood Banks; Diagnostic Centers & Laboratories; OthersBlood Banks (53.4% share)Diagnostic Centers & Laboratories (8.1% CAGR)
By RegionNorth America; Europe; Asia-Pacific; South America; Middle East & AfricaNorth America (36.9% share)Asia-Pacific (6.8% CAGR)

Market Segmentation Overview

By End-user

Sub-SegmentKey Trend
Hospitals & ClinicsCell salvage, viscoelastic testing, and protocol software adopted to meet accreditation and value-based targets
Blood BanksAutomated whole blood processing and expanded donor screening drive equipment and disposables demand
Diagnostic Centers & LaboratoriesPre-surgical anemia and coagulation testing shifts into outpatient settings
OthersAmbulatory surgery centers extend blood management protocols beyond the hospital

Blood banks lead the end-user dimension of the Patient Blood Management Market with a 53.4% share because they buy processing systems, screening assays, and disposables at the highest volumes, and new traceability rules are accelerating their automation spend. Diagnostic centers & laboratories grow fastest at an 8.1% CAGR as anemia screening moves weeks ahead of elective surgery into outpatient settings. Hospitals & clinics remain the main venue for protocol-driven purchases such as cell salvage and point-of-care coagulation testing, while the other category gains share as procedures migrate to ambulatory centers.

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.